Biosimilars: International Market Trends and Current Status in Canada

The top 10 biologics globally are now either marketed or in the pipeline in most countries as biosimilars. In Canada there are currently six marketed biosimilars but this number is expected to increase dramatically over the next few years. McKesson Canada can help with product launch strategies that require Patient Assistance Programs with a focus on Patient Adherence, Brand Strategy and Consulting, and expertly lead Risk Management Plan submissions and programs.

Courtesy of McKesson Canada.